Argentine lab says agrees deal to produce Russia’s Sputnik V vaccine

Laboratorios Richmond has signed a memorandum of understanding with Russia’s RDIF sovereign wealth fund to be able to manufacture the vaccine, which has so far been the main drug used in Argentina’s fledgling inoculation program.

RIO DE JANEIRO, BRAZIL - An Argentine laboratory has struck a deal to help produce Russia’s COVID-19 vaccine Sputnik V, according to a company statement shared by the country’s government on Friday, helping pump up the local firm’s share price.

Laboratorios Richmond has signed a memorandum of understanding with Russia’s RDIF sovereign wealth fund to be able to manufacture the vaccine, which has so far been the main drug used in Argentina’s fledgling inoculation program.

Argentina was one of the first countries in the region to sign an agreement with Russia to buy Sputnik V . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?